Abstract
Ornithine decarboxylase (ODC), the first rate-limiting enzyme of polyamine biosynthesis, was found to be associated with cell growth, proliferation and transformation. ODC gene expression in gastric cancer was increased and its level was positively correlated with the degree of malignity of gastric mucosa and development of gastric lesions. In order to evaluate the therapeutic effects of antisense RNA of ODC on gastric cancer, an antisense RNA of ODC expressing plasmid pcDNA-ODCr which delivered a 120 bp fragment complementary to the initiation codon of ODC gene was constructed and transfected to gastric cancer cells SGC7901 and MGC803. Expression of ODC in gastric cancer cells was determined by western blot. Cell proliferation was assessed by MTS assay. Cell cycle was analyzed by flow cytometry and Matrigel assay was performed to assess the ability of gastric cancer cell invasiveness. The results showed that the ODC gene expression in gastric cancer cells transfected with the pcDNA-ODCr was downregulated efficiently. Tumor cell proliferation was suppressed significantly, and cell cycle was arrested at G1 phase. Gastric cancer cells had reduced invasiveness after gene transfer. Our study suggested that antisense RNA of ODC expressing plasmid pcDNA-ODCr had antitumor activity by inhibiting the expression of ODC, and downregulation of ODC expression using a gene therapy approach might be a novel therapeutic strategy for gastric cancer.
Similar content being viewed by others
References
Wang N, Dong XJ, Zhou RM, Guo W, Zhang XJ, Li Y (2009) An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China. Mol Biol Rep 36(2):357–364
Li Y, Sun DL, Duan YN, Zhang XJ, Wang N, Zhou RM, Chen ZF, Wang SJ (2010) Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Mol Biol Rep 37(1):197–205
Souza RF, Spechler SJ (2005) Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA Cancer J Clin 55(6):334–351
Zhang Q, Li Y, Li X, Zhou W, Shi B, Chen H, Yuan W (2009) PARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population. Mol Biol Rep 36(6):1461–1467
Masoudi M, Saadat I, Omidvari S, Saadat M (2009) Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep 36(4):781–784
Zhang L, Huang H, Wu K, Wang M, Wu B (2009) Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro. Mol Biol Rep. doi:10.1007/s11033-009-9777-y
Hou R, Cao B, Chen Z, Li Y, Ning T, Li C, Xu C, Chen Z (2010) Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer. Mol Biol Rep 37(1):515–520
Shi L, Zhao M, Luo Q, Ma YM, Zhong JL, Yuan XH, Huang CZ (2009) Overexpression of PIP5KL1 suppresses cell proliferation and migration in human gastric cancer cells. Mol Biol Rep. doi:10.1007/s11033-009-9701-5
Pegg AE, Madhubala R, Kameji T, Bergeron RJ (1998) Control of ornithine decarboxylase activity in alpha-difluoromethylornithine-resistant L1210 cells by polyamines and synthetic analogues. J Biol Chem 263:11008–11014
Sistonen L, Holtta E, Lehvaslaiho H, Lehtola L, Alitalo K (1989) Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase. J Cell Biol 109:1911–1919
Holtta E, Sistonen L, Alitalo K (1988) The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J Biol Chem 263:4500–4507
Sakata H, Ootani A, Fujise T, Sakata Y, Wu B, Tsunada S (2005) Decreased apoptosis and increased ornithine decarboxylase activity in the intestinal mucosa of rats with bilateral ventromedial hypothalamus lesions. J Gastroenterol 40:137–142
Ray RM, Zimmerman BJ, McCormack SA, Patel TB, Johnson LR (1999) Polyamine depletion arrests cell cycle and induces inhibitors p21Waf1/Cip1, p27Kip1, and p53 in IEC-6 cells. Am J Physiol 276:684–691
Kubota S, Kiyosawa H, Nomura Y, Yamada T, Seyama Y (1997) Ornithine decarboxylase overexpression in mouse 10T1/2 fi broblasts: cellular transformation and invasion. J Natl Cancer Inst 89:567–571
Auvinen M, Paasinen A, Andersson LC, Hölttä E (1992) Ornithine decarboxylase activity is critical for cell transformation. Nature 360:355–358
Auvinen M, Laine A, Paasinen-Sohns A, Kangas A, Kangas L, Saksela O, Andersson LC, Hölttä E (1997) Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res 57:3016–3025
Moshier JA, Dosescu J, Skunca M, Luk GD (1993) Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res 53:2618–2622
Mori M, Honda M, Shibuta K, Baba K, Nakashima H, Haraguchi M, Koba F, Ueo H, Sugimachi K, Akiyoshi T (1996) Expression of ornithine decarboxylase mRNA in gastric carcinoma. Cancer 77:1634–1638
Miao XP, Li JS, Li HY, Zeng SP, Zhao Y, Zeng JZ (2007) Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions. World J Gastroenterol 13:2867–2871
Hu HY, Liu XX, Jiang CY, Lu Y, Liu SL, Bian JF, Wang XM, Geng Z, Zhang Y, Zhang B (2005) Ornithine decarboxylase gene is overexpressed in colorectal carcinoma. World J Gastroenterol 11:2244–2248
Tian H, Huang Q, Li L, Liu XX, Zhang Z (2006) Gene expression of ornithine decarboxylase in lung cancers and its clinical significance. Acta Biochim Biophys Sin 38(9):639–645
Mimori K, Mori M, Shiraishi T, Tanaka S, Haraguchi M, Ueo H, Shirasaka C, Akiyoshi T (1998) Expression of ornithine decarboxylase mRNA and c-myc mRNA in breast tumours. Int J Oncol 12:597–601
Canizares F, Salinas J, de las Heras M, Tovar I, Martinez P, Penafiel R (1999) Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Clin Cancer Res 5:2035–2041
Ernestus RI, Rohn G, Schroder R, Els T, Klekner A, Paschen W, Klug N (2001) Polyamine metabolism in brain tumours: diagnostic relevance of quantitative biochemistry. J Neurol Neurosurg Psychiatry 71:88–92
Subhi AL, Tang B, Balsara BR, Altomare DA, Testa JR, Cooper HS, Hoffman JP, Meropol NJ, Kruger WD (2004) Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer. Clin Cancer Res 10:7290–7296
Young L, Salomon R, Au W, Allan C, Russell P, Dong Q (2006) Ornithine decarboxylase (ODC) expression pattern in human prostate tissues and ODC transgenic mice. J Histochem Cytochem 54:223–229
Faaland CA, Thomas TJ, Balabhadrapathruni S, Langer T, Mian S, Shirahata A, Gallo MA, Thomas T (2000) Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis. Biochem Cell Biol 78:415–426
McCann PP, Pegg AE, Sjoerdsma AP (1987) Inhibition of polyamine metabolism: biological significance and basis of new therapies. Academic Press, Orlando, FL
Thomas T, Kiang DT (1987) Additive growth-inhibitory effects of difluoromethylornithine and antiestrogens on MCF-7 cell line. Biochem Biophys Res Commun 148:1338–1345
Xu J, Gao DF, Yan GL, Fan JM (2009) Induced apoptotic action of recombinant trichosanthin in human stomach adenocarcinoma MCG803 cells. Mol Biol Rep 36(6):1559–1564
Zhang B, Liu XX, Zhang Y, Jiang CY, Hu HY, Gong L (2005) The screening of the sensitive antisense target in the ODC mRNA. J Shandong Univ 8:146–150
Marton LJ, Pegg AE (1995) Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35:55–91
Coffino P, Poznanski A (1991) Killer polyamines? J Cell Biochem 45:54–58
Coffino P (2001) Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2:188–194
Gandre S, Bercovich Z, Kahana C (2002) Ornithine decarboxylase-antizyme is rapidly degraded through a mechanism that requires functional ubiquitin-dependent proteolytic activity. Eur J Biochem 269:1316–1322
Rich TA, Skibber JM, Ajani JA, Buchholz DJ, Gleary KR, Dubrow RA, Levin B, Lynch PM, Metedssian SH, Roubin LD et al (1995) Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 32:1025–1029
Love RR, Astrow SH, Cheeks AM, Havighurst TC (2003) Ornithine decarboxylase (ODC) as a prognostic factor in operable breast cancer. Breast Cancer Res Treat 79:329–334
Martínez ME, O’Brien TG, Fultz KE, Babbar N, Yerushalmi H, Qu N, Guo Y, Boorman D, Einspahr J, Alberts DS, Gerner EW (2003) Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci USA 100:7859–7864
Gamet L, Cazenave Y, Trocheris V, Denis-Pouxviel C, Murat JC (1991) Involvement of ornithine decarboxylase in the control of proliferation of the HT29 human colon cancer cell line. Effect of vasoactive intestinal peptide on enzyme activity. Int J Cancer 47:633–638
Tian H, Li L, Liu XX, Zhang Z (2006) Antitumor effect of antisense ODC adenovirus on human lung cancer cells. Acta Biochim Biophys Sin 38(6):410–416
Zhang Y, Liu XX, Zhang B, Hu HY, Gong L (2005) Antitumor effect of antisense ODC adenovirus on human prostate cancer cells. Prostate Cancer Prostatic Dis 8:280–286
Chi WL, Song XR, Jiang CY, Liu XX, Li WT, Wang XW (2006) Lentiviral vector-mediated downregulation of ornithine decarboxylase inhibits tumor cell growth in vitro and in vivo. Tumor Biol 27:243–251
Acknowledgments
This work was supported by the Foundation of the Department of Science and Technology of Shandong Province (No: 2008GG30002030).
Author information
Authors and Affiliations
Corresponding author
Additional information
Chun-xiao Xu, Yun-fei Yan, and Ya-pei Yang have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Xu, Cx., Yan, Yf., Yang, Yp. et al. Downregulation of ornithine decarboxylase by pcDNA-ODCr inhibits gastric cancer cell growth in vitro. Mol Biol Rep 38, 949–955 (2011). https://doi.org/10.1007/s11033-010-0188-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-010-0188-x